1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550(
- Contribution to journal › Article
- 1998
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article
-
Mark
Psychological profile related to malignant tumours of different histopathology
(
- Contribution to journal › Article
-
Mark
Attitude towards aggression and creative functioning in patients with breast cancer
(
- Contribution to journal › Article
- 1997
-
Mark
Induction chemotherapy with versus without hormonal synchronisation in locally advanced breast cancer
(
- Contribution to journal › Article
- 1995
-
Mark
CAVIAR : a tool to improve serial analysis of the 12-lead electrocardiogram
(
- Contribution to journal › Article
- 1991
-
Mark
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4
(
- Contribution to journal › Article